NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/05/2026
Back to search
Official data from USPTO
RITE3
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
05/05/2026
Trademark type
Word
Nice classes
42
Filing date
08/30/2024
Registration date
05/05/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/05/2026
Last transaction
05/05/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/28/2025
First use in commerce
01/28/2025
Drawing code
4
Owner type
03
Owner location
King of Prussia, PA, US
Examiner
AMIN,NOOPUR H
Law office
O60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SEED Therapeutics US, Inc.
Representatives
Ian W. Gillies Knobbe Martens Olson & Bear, LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
drug discoverypharmaceutical drug developmentdrug validation services in the field of targeted disease-causing or disease-associated protein degradation; pharmaceutical research and development servicesin particular for identifying ubiquitin ligases; providing medical research and scientific information related to ubiquitin ligase identification and targeted disease-causing or disease-associated protein degradation in the fields of pharmaceuticalsbiological life scienceschemistrybiochemistrybiotechnologyclinical trials; providing scientificmedical research information related to targeted disease-causing or disease-associated protein degradation in the field of pharmaceutical and clinical trials via the internet; consulting services in the fields of pharmaceutical researchbiological life sciencespharmaceutical chemistrybiochemistrybiotechnologyclinical trialsall related to targeted disease-causing or disease-associated protein degradation; research and development of new products in the field of targeted disease-causing or disease-associated protein degradation and the identification of ubiquitin ligases; pharmaceuticalscientificmedicalclinical research and development services in the field of targeted disease-causing or disease-associated protein degradation; providing information about scientificpharmaceuticalclinicalmedical researchdrug discoverydevelopment and validation information related to a method of ligase selection to discover molecules and drugs that cause targeted disease-causing or disease-associated protein degradation; Scientific and technological servicestechnical biology consulting servicesin particular for identifying ubiquitin ligases
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/05/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/14/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/14/2026
EEXT
SOU TEAS EXTENSION RECEIVED
04/13/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/03/2026
IUAF
USE AMENDMENT FILED
10/15/2025
EISU
TEAS STATEMENT OF USE RECEIVED
10/15/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/14/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/19/2025
PUBO
PUBLISHED FOR OPPOSITION
08/19/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/13/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/16/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/12/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/12/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/12/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/13/2025
GNRT
NON-FINAL ACTION E-MAILED
03/13/2025
CNRT
NON-FINAL ACTION WRITTEN
03/13/2025
DOCK
ASSIGNED TO EXAMINER
03/13/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/12/2025
NWAP
NEW APPLICATION ENTERED
08/30/2024
Continuous trademark protection
Get notified about every new filing that threatens RITE3 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.